Search For "zydus"
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 12 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Cyril Amarchand Mangaldas advises Zydus Cadila on sale of its India-focuse
Updated : 5 years ago IST
New Delhi/ Mumbai (Maharashtra) [India], May14 (NewsVoir): Cyril Amarchand Mangaldas advised Zydus Cadila on sale of its India-focussed animal healthcare business to Zenex Animal Health India Private Limited (Zenex), which is a special purpose vehicle set up by Multiples led consortium of in
Read More
Zydus Cadila to sell one animal health business for Rs 2,921 crore
Updated : 5 years ago IST
Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore.
Read More
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-
Updated : 5 years ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Read More
Zydus' Virafin gets emergency use approval for treating moderate COVID-19
Updated : 5 years ago IST
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Read More
Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 trea
Updated : 5 years, 1 month ago IST
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Read More
Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore
Updated : 5 years, 3 months ago IST
Ahmedabad (Gujarat) [India], February 5 (ANI): Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the corresponding quarter of previous year.
Read More
Paradigm shift in Cancer: Complete care under the same roof in Ahmedabad -
Updated : 5 years, 4 months ago IST
Ahmedabad (Gujarat) [India], January 5 (ANI/Mediawire): Today, the future of healthcare lies in ability and agility to inculcate the latest technology and being ahead of the times in terms of prevention, diagnosis and treatment.
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 4 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
India reports 41,322 new COVID-19 cases; PM reviews development, manufactu
Updated : 5 years, 5 months ago IST
New Delhi [India], November 28 (ANI): As the country reported 41,322 new cases of the novel coronavirus in the last 24 hours, Prime Minister Narendra Modi on Saturday held a three-city tour to Pune, Ahmedabad and Hyderabad to personally review the development and manufacturing of the vaccine
Read More
PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila
Updated : 5 years, 5 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Zydus Cadila chairperson Pankaj K Patel said on Saturday that Prime Minister Narendra Modi's visit to Zydus Biotech Park here had encouraged the staff to "doing more and doing fast" in relation to the COVID-19 vaccine and his knowledge, wisd
Read More
PM Modi visits Bharat Biotech vaccine facility, Zydus Biotech Park
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited the manufacturing facility of Bharat Biotech International Limited (BBIL) in Telangana to review the development of its 'Covaxin' Covid-19 vaccine candidate.
Read More